Fatigue as a Residual Symptom of Depression
Steven D. Targum, MD
and
Maurizio Fava, MD
Author information ► Copyright and License information ►
This article has been
cited by other articles in PMC.
Go to:
Introduction
It is well recognized that many patients with major depressive disorder (MDD) do not achieve a full response to antidepressant medications despite adequate dose and duration of the treatment. One of the most common residual symptoms of a partially resolved depression is fatigue. Broadly defined, symptoms of fatigue can affect physical, cognitive, and emotional function, impair school and work performance, disturb social and family relationships, and increase healthcare utilization. Furthermore, some of the medications we use to treat MDD can induce symptoms of fatigue as side effects. Given the importance and complexity of fatigue occurring in patients with MDD, I discussed this topic with Maurizio Fava MD, Slater Family Professor of Psychiatry at the Harvard Medical School. Dr. Fava is also Executive Vice Chair of the Department of Psychiatry, Executive Director of the MGH Clinical Trials Network and Institute (CTNI), and Director of the Depression Clinical and Research Program at the Massachusetts General Hospital, in Boston, Massachusetts.
Go to:
Dr. Fava, how often do we observe symptoms of fatigue in MDD?
Dr. Fava: We see prominent symptoms of fatigue in the majority of patients with depression. In fact, fatigue is one of the most prevalent presenting symptoms of MDD, the second most prominent residual symptom of MDD, and is often associated with impaired concentration, irritability, and reduced productivity.
1–
3 Further, up to one-third of MDD patients who have achieved remission or response stiH continue to experience some symptoms of fatigue.
1,
2 In one recent study, more than 90 percent of patients with MDD had severe fatigue despite the fact that more than 80 percent of these patients were already taking antidepressant medications.
4 In this study of 66 patients with MDD, 81.5 percent were taking antidepressant medications: 48.2 percent were taking selective serotonin reuptake inhibitors (SSRIs) and 33.3 percent were taking serotonin norepinephrine reuptake inhibitors (SNRIs).
Go to:
How do you define fatigue in depression?
Dr. Fava: Fatigue is one of the identified symptoms of MDD listed in the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria where it is defined as physical fatigue or loss of energy. However, in my opinion, fatigue is much more than that. We see apathy and considerable emotional disturbance occurring as a consequence of fatigue. We have also seen high rates of diminished focus, word finding difficulties, and recall problems in fatigued patients with MDD.
2 Recently, Arnold
5 described three distinct categories of fatigue that commonly occur within a population of MDD patients: physical, cognitive, and emotional symptoms. The physical symptoms of fatigue include reduced activity, low energy, tiredness, decreased physical endurance, increased effort to do physical tasks, general weakness, heaviness, slowness or sluggishness, nonrestorative sleep, and sleepiness. The cognitive symptoms include decreased concentration, decreased attention, decreased mental endurance, and slowed thinking. The emotional (affective) symptoms of fatigue include decreased motivation or initiative (apathy), decreased interest, feeling overwhelmed, feeling bored, aversion to effort, and feeling low. Given the broad range of related, comorbid symptoms, it can be difficult to differentiate between independent symptoms of fatigue from symptoms directly related to MDD.
Go to:
What are the consequences of residual symptoms of fatigue in MDD?
Dr. Fava: The key point is that patients with residual fatigue are more likely to get depressed again despite continued prophylactic treatment. There is a much greater likelihood that patients with MDD who have residual symptoms like fatigue will also have work, school, and/or social difficulties. As you know, there is a very high medical comorbidity associated with depression as well. Therefore, we need to identify these symptoms and intervene as early as possible.
Go to:
How do you assess the symptoms of fatigue in MDD?
Dr. Fava: First, I want to confirm that the patient actually has a diagnosis of MDD. There may be some patients who complain of many symptoms of fatigue but do not have MDD, or there may be some patients with comorbid illnesses that include some depressive symptoms and fatigue, but are not truly MDD. Second, it is really important to differentiate between symptoms of fatigue that have been caused by the drugs we are using to treat the MDD in contrast to symptoms that are present as residual symptoms of MDD.
I begin my assessment by obtaining a careful, detailed history of all of the symptoms that existed prior to the initiation of treatment, followed by identifying any symptoms that have persisted despite treatment, and then I ask about any new symptoms that have emerged during treatment. Treatment-emergent symptoms may or may not be caused by the medications we are using, but it is important to differentiate whether these symptom are new or were preexisting to the treatment. Obviously, it is also important to explore whether the residual symptoms are more or less severe than they were before treatment commenced.
…patients with residual fatigue are more likely to get depressed again despite continued prophylactic treatment. There is a much greater likelihood that patients with MDD who have residual symptoms like fatigue will also have work, school, and/or social difficulties.
I may also have the patient fill out a comprehensive psychopharmacological history scale, such as the Massachusetts General Hospital (MGH) Antidepressant Treatment Response Questionnaire (MGH-ATRQ), as this type of tool is useful for this assessment.
6 It is helpful to know whether previous medications have had the same effects or caused different symptoms.
Based upon both my review of symptoms past and present and my psychopharmacological review, I can often pinpoint whether the identified fatigue symptoms are truly residual symptoms of MDD or side effects of treatment.
I also try to quantify the severity of the fatigue symptoms as a baseline for subsequent intervention.